Quantitative differences in the immunomodulatory effects of Rebif and Avonex in IFN-β 1a treated multiple sclerosis patients

類似資料

• SHP-1 deficiency and increased inflammatory gene expression in PBMCs of multiple sclerosis patients
  著者:: Christophi, George P, 等
  出版事項: (2008)
• Interferon-β treatment in multiple sclerosis attenuates inflammatory gene expression through inducible activity of the phosphatase SHP-1
  著者:: Christophi, George P., 等
  出版事項: (2009)
• Interleukin-33 upregulation in peripheral leukocytes and CNS of multiple sclerosis patients
  著者:: Christophi, George P., 等
  出版事項: (2011)
• The Therapeutic Effect of Avonex, Rebif and Betaferon on EDSS and Relapse in Multiple Sclerosis: A Comparative Study
  著者:: Mehrdokht Mazdeh, 等
  出版事項: (2010-03-01)
• Macrophages of multiple sclerosis patients display deficient SHP-1 expression and enhanced inflammatory phenotype
  著者:: Christophi, George P., 等
  出版事項: (2009)